Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Feb;14(1):79-93.
doi: 10.1007/BF01059285.

Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve

Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve

B Hecquet et al. J Pharmacokinet Biopharm. 1986 Feb.

Abstract

A mathematical model for area under the curve (AUC) determination is proposed taking into account the circadian variation of cisplatin protein binding. The main theoretical result obtained with the model is that early morning drug administration (2-4 AM) promotes the highest AUC. The model predicts a maximum AUC variation, due to the binding variation, ranging between 2.4 and 15%. The minimum of AUC between 2.45 and 3.30 PM is in agreement with the minimum nephrotoxicity observed when cisplatin is injected in the afternoon. The model can be applied to other drugs that are irreversively bound to proteins or irreversively bound to other plasma components if the binding rate depends on the time of day. The variation intensity of AUC was demonstrated to depend on drug characteristics, but can never be higher than the circadian variation of the protein binding rate.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Cancer Clin Oncol. 1982 May;18(5):471-7 - PubMed
    1. Anticancer Res. 1981;1(4):199-204 - PubMed
    1. Cancer Res. 1982 Mar;42(3):950-5 - PubMed
    1. Fed Proc. 1983 Oct;42(13):2974-8 - PubMed
    1. Cancer Chemother Pharmacol. 1980;5(1):21-6 - PubMed